Skip to main content
. Author manuscript; available in PMC: 2023 Apr 24.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Apr 3;20(8):1748–1756.e11. doi: 10.1016/j.cgh.2021.03.049

Table 3.

Change in Endoscopic Abnormalities and Symptoms With 1FED in Pediatric EoE

n Pretreatment n Post-treatment P valuea

Endoscopic findings, n (%)
 Edema 41 32 (78) 41 22 (54) .01
 Exudate 41 24 (59) 41 10 (24) .001
 Furrows 41 32 (78) 41 22 (54) .02
 Rings 41 8 (20) 41 16 (39) .04
 Stricture 41 0 (0) 41 1 (2) NDb
Inflammatory sum,c median [IQR] 41 2 [2–3] 41 1 [0–2] <.001
Sum,b median [IQR] 41 3 [2–3] 41 2 [1–3] .009
Symptoms, n (%)
 Abdominal pain 41 13 (32) 38 16 (42) .45
 Chest pain 39 10 (26) 37 3 (8) .039
 Dysphagia 39 17 (44) 38 6 (16) .002
 Early satiety 35 15 (43) 37 16 (43) 1.00
 Feeding difficulties 39 10 (26) 37 9 (24) 1.00
 Food impaction 38 10 (26) 38 5 (13) .15
 Gagging/choking 37 7 (19) 37 2 (5) .22
 Heartburn 37 9 (24) 37 8 (22) 1.00
 Nausea 38 10 (26) 38 10 (26) .77
 Odynophagia 37 5 (14) 37 1 (3) .22
 Pockets or spits out food 36 10 (28) 37 3 (8) .039
 Poor appetite 37 10 (27) 37 5 (14) .13
 Reflux or regurgitation 36 11 (31) 36 8 (22) .69
 Slow eating 38 19 (50) 37 11 (30) .11
 Vomiting 41 14 (34) 38 7 (18) .15
 Night wakening 35 7 (19) 35 3 (9) .51
Symptom sum,d median [IQR] 41 4 [3–6] 38 3 [1–5] .003

NOTE. The Wilcoxon signed-ranked test was used for paired endoscopy and symptom scores. Significant values are bolded, P < .05.

IQR, interquartile range; 1FED, 1-food elimination diet; ND, not determined.

a

Comparison by McNemar test was performed for dichotomous paired data.

b

Sum of edema, exudate, rings, furrows.

c

Sum of edema, exudate, and furrows.

d

Sum of symptoms that are present.